My breast cancer spread to my lymph nodes. Can FEMARA help reduce my risk of cancer coming back?
For women whose cancer has spread to the lymph nodes, the risk of relapse may be more significant. Oncologists may recommend FEMARA due to results from a clinical trial which showed that FEMARA was more effective than tamoxifen by 29% at reducing the risk of cancer returning in women with node-positive breast cancer1. 185 out of 1,660 (11.1%) patients taking FEMARA recurred versus 247 out of 1,651 (15%) patients taking tamoxifen.